Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan

American Journal of Gastroenterology

Volumn 111, Issue 9, 2016, Pages 1313-1319

  Wang, Li Hui ^a   Yang, Yao Jong ^b   Cheng, Wei Chun ^b   Wang, Wei Ming ^b   Lin, Sheng Hsiang ^c   Shieh, Chi Chang ^b,c  

^a KUO GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL CANCER; COMPARATIVE STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; ICD-9; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; POPULATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STANDARDIZED INCIDENCE RATIO; TAIWAN; ULCERATIVE COLITIS; ADOLESCENT; CHILD; COLITIS, ULCERATIVE; FACTUAL DATABASE; HEMATOLOGIC NEOPLASMS; INCIDENCE; INFANT; INFLAMMATORY BOWEL DISEASES; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEOPLASMS; NEWBORN; PRESCHOOL CHILD; PREVALENCE; REGISTER; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DATABASES, FACTUAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84984870540     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.239     Document Type: Article

References (25)

1. Chuang CH, Lin SH, Chen CY et al. Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a lowendemic area 1998-2010. Inflamm Bowel Dis 2013; 19: 2815-9.
2. Ng SC, Tang W, Ching JY et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013; 145: 158-65.e2.
3. Vesely MD, Kershaw MH, Schreiber RD et al. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29: 235-71.
4. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4: 221-33.
5. Biancone L, Onali S, Petruzziello C et al. Cancer and immunomodulators in inflammatory bowel diseases. Inflamm Bowel Dis 2015; 21: 674-98.
6. Ekbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
7. Herrinton LJ, Liu L, Levin TR et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012; 143: 382-9.
8. Baecklund E, Smedby KE, Sutton LA et al. Lymphoma development in patients with autoimmune and inflammatory disorders-what are the driving forces? Semin Cancer Biol 2014; 24: 61-70.
9. Fallah M, Liu X, Ji J et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014; 25: 2025-30.
10. Chen YJ, Chang YT, Wang CB et al. The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan. Arthritis Rheum 2011; 63: 352-8.
11. Wang LH, Wang WM, Hsu SM et al. Risk of overall and site-specific cancers in behcet disease: a nationwide population-based study in Taiwan. J Rheumatol 2015; 42: 879-84
12. Bernstein CN, Blanchard JF, Kliewer E et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001; 91: 854-62.
13. Kappelman MD, Farkas DK, Long MD et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol 2014; 12: 265-73.
14. Jess T, Horvath-Puho E, Fallingborg J et al. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol 2013; 108: 1869-76.
15. Yadav S, Singh S, Harmsen WS et al. Effect of medications on risk of cancer in patients with inflammatory bowel diseases: a population-based cohort study from Olmsted County, Minnesota. Mayo Clin Proc 2015; 90: 738-46.
16. Yeh H-Y, Wu J-C, Haschler I et al. Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 2011; 86: 365-80.
17. National Health Insurance Administration. Patients with Catastropic Illnesses. Available at: http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11& menu-id=596&WD-ID=596&webdata-id=3180 (Last accessed 15 March 2016).
18. Cohort Study: Standardized Incidence Ratio (SIR). Available at: http://epiville. ccnmtl.columbia.edu/99interactive/sir.html (Last accessed 15 March 2016).
19. Thia KT, Loftus EV Jr, Sandborn WJ et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103: 3167-82.
20. Ng SC, Tsoi KK, Kamm MA et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis 2012; 18: 1164-76.
21. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med 2015; 372: 1441-52.
22. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
23. Jess T, Simonsen J, Jorgensen KT et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroentero logy 2012; 143: 375-81.
24. Nguyen GC, Bressler B. A tale of two cohorts: are we overestimating the risk of colorectal cancer in inflammatory bowel disease? Gastroenterology 2012; 143: 288-90.
25. Lutgens MW, van Oijen MG, van der Heijden GJ et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013; 19: 789-99.